Dr. William Pao, director of the division of hematology and oncology at Vanderbilt-Ingram Cancer Center, explains what personalized cancer medicine means for the future of lung cancer treatment. You can also see Dr. Pao on December 14 from 1:30-2 p.m. CST during a live video chat as he and Dr. Mia Levy discuss DNA-driven cancer care. Learn more and register for the live chat: http://www.MyHealthChat.com
National Cancer Institute : The cost of cancer in 2020 in the U.S. is projected to reach at least $158 billion (in 2010 dollars). Assuming a 2 percent annual increase in medical costs in the initial and final phases of care, the projected 2020 costs increase to $173 billion. Estimating a 5 percent annual increase in these costs raises the projection to $207 billion. These figures do not include other types of costs, such as lost productivity, which add to the overall financial burden of cancer.
procommenter 1 month ago